List of Tables
Table 1. Global End-stage Renal Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Drugs
Table 3. Key Players of Device
Table 4. Key Players of Other
Table 5. Global End-stage Renal Disease Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global End-stage Renal Disease Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global End-stage Renal Disease Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 8. Global End-stage Renal Disease Therapeutics Market Share by Region (2021–2026)
Table 9. Global End-stage Renal Disease Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global End-stage Renal Disease Therapeutics Market Share by Region (2027–2032)
Table 11. End-stage Renal Disease Therapeutics Market Trends
Table 12. End-stage Renal Disease Therapeutics Market Drivers
Table 13. End-stage Renal Disease Therapeutics Market Challenges
Table 14. End-stage Renal Disease Therapeutics Market Restraints
Table 15. Global End-stage Renal Disease Therapeutics Revenue by Players (US$ Million), 2021–2026
Table 16. Global End-stage Renal Disease Therapeutics Market Share by Players (2021–2026)
Table 17. Global Top End-stage Renal Disease Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on End-stage Renal Disease Therapeutics Revenue, 2025
Table 18. Ranking of Global Top End-stage Renal Disease Therapeutics Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by End-stage Renal Disease Therapeutics Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of End-stage Renal Disease Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of End-stage Renal Disease Therapeutics, Products and Applications
Table 22. Global Key Players of End-stage Renal Disease Therapeutics, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global End-stage Renal Disease Therapeutics Market Size by Type (US$ Million), 2021–2026
Table 25. Global End-stage Renal Disease Therapeutics Revenue Market Share by Type (2021–2026)
Table 26. Global End-stage Renal Disease Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global End-stage Renal Disease Therapeutics Revenue Market Share by Type (2027–2032)
Table 28. Global End-stage Renal Disease Therapeutics Market Size by Application (US$ Million), 2021–2026
Table 29. Global End-stage Renal Disease Therapeutics Revenue Market Share by Application (2021–2026)
Table 30. Global End-stage Renal Disease Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global End-stage Renal Disease Therapeutics Revenue Market Share by Application (2027–2032)
Table 32. North America End-stage Renal Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America End-stage Renal Disease Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 34. North America End-stage Renal Disease Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 35. Europe End-stage Renal Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe End-stage Renal Disease Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 37. Europe End-stage Renal Disease Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific End-stage Renal Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific End-stage Renal Disease Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific End-stage Renal Disease Therapeutics Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America End-stage Renal Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America End-stage Renal Disease Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America End-stage Renal Disease Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa End-stage Renal Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa End-stage Renal Disease Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa End-stage Renal Disease Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 47. Fresenius Company Details
Table 48. Fresenius Business Overview
Table 49. Fresenius End-stage Renal Disease Therapeutics Product
Table 50. Fresenius Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 51. Fresenius Recent Development
Table 52. Nikkiso Company Details
Table 53. Nikkiso Business Overview
Table 54. Nikkiso End-stage Renal Disease Therapeutics Product
Table 55. Nikkiso Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 56. Nikkiso Recent Development
Table 57. B.Braun Company Details
Table 58. B.Braun Business Overview
Table 59. B.Braun End-stage Renal Disease Therapeutics Product
Table 60. B.Braun Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 61. B.Braun Recent Development
Table 62. Baxter Company Details
Table 63. Baxter Business Overview
Table 64. Baxter End-stage Renal Disease Therapeutics Product
Table 65. Baxter Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 66. Baxter Recent Development
Table 67. Asahi Kasei Company Details
Table 68. Asahi Kasei Business Overview
Table 69. Asahi Kasei End-stage Renal Disease Therapeutics Product
Table 70. Asahi Kasei Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 71. Asahi Kasei Recent Development
Table 72. Nipro Company Details
Table 73. Nipro Business Overview
Table 74. Nipro End-stage Renal Disease Therapeutics Product
Table 75. Nipro Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 76. Nipro Recent Development
Table 77. Weigao Company Details
Table 78. Weigao Business Overview
Table 79. Weigao End-stage Renal Disease Therapeutics Product
Table 80. Weigao Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 81. Weigao Recent Development
Table 82. Toray Company Details
Table 83. Toray Business Overview
Table 84. Toray End-stage Renal Disease Therapeutics Product
Table 85. Toray Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 86. Toray Recent Development
Table 87. Medtronic Company Details
Table 88. Medtronic Business Overview
Table 89. Medtronic End-stage Renal Disease Therapeutics Product
Table 90. Medtronic Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 91. Medtronic Recent Development
Table 92. JMS Company Details
Table 93. JMS Business Overview
Table 94. JMS End-stage Renal Disease Therapeutics Product
Table 95. JMS Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 96. JMS Recent Development
Table 97. SB-KAWASUMI Company Details
Table 98. SB-KAWASUMI Business Overview
Table 99. SB-KAWASUMI End-stage Renal Disease Therapeutics Product
Table 100. SB-KAWASUMI Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 101. SB-KAWASUMI Recent Development
Table 102. Medica Group Company Details
Table 103. Medica Group Business Overview
Table 104. Medica Group End-stage Renal Disease Therapeutics Product
Table 105. Medica Group Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 106. Medica Group Recent Development
Table 107. Chongqing Shanwaishan Company Details
Table 108. Chongqing Shanwaishan Business Overview
Table 109. Chongqing Shanwaishan End-stage Renal Disease Therapeutics Product
Table 110. Chongqing Shanwaishan Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 111. Chongqing Shanwaishan Recent Development
Table 112. Amgen Company Details
Table 113. Amgen Business Overview
Table 114. Amgen End-stage Renal Disease Therapeutics Product
Table 115. Amgen Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 116. Amgen Recent Development
Table 117. Deltanoid Company Details
Table 118. Deltanoid Business Overview
Table 119. Deltanoid End-stage Renal Disease Therapeutics Product
Table 120. Deltanoid Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 121. Deltanoid Recent Development
Table 122. AbbVie Company Details
Table 123. AbbVie Business Overview
Table 124. AbbVie End-stage Renal Disease Therapeutics Product
Table 125. AbbVie Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 126. AbbVie Recent Development
Table 127. Sanofi Company Details
Table 128. Sanofi Business Overview
Table 129. Sanofi End-stage Renal Disease Therapeutics Product
Table 130. Sanofi Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 131. Sanofi Recent Development
Table 132. Ardelyx Company Details
Table 133. Ardelyx Business Overview
Table 134. Ardelyx End-stage Renal Disease Therapeutics Product
Table 135. Ardelyx Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 136. Ardelyx Recent Development
Table 137. AstraZeneca Company Details
Table 138. AstraZeneca Business Overview
Table 139. AstraZeneca End-stage Renal Disease Therapeutics Product
Table 140. AstraZeneca Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 141. AstraZeneca Recent Development
Table 142. Kyowa Hakko Kirin Company Details
Table 143. Kyowa Hakko Kirin Business Overview
Table 144. Kyowa Hakko Kirin End-stage Renal Disease Therapeutics Product
Table 145. Kyowa Hakko Kirin Revenue in End-stage Renal Disease Therapeutics Business (US$ Million), 2021–2026
Table 146. Kyowa Hakko Kirin Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. End-stage Renal Disease Therapeutics Picture
Figure 2. Global End-stage Renal Disease Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global End-stage Renal Disease Therapeutics Market Share by Type: 2025 vs 2032
Figure 4. Drugs Features
Figure 5. Device Features
Figure 6. Other Features
Figure 7. Global End-stage Renal Disease Therapeutics Market Size by Application (US$ Million), 2021–2032
Figure 8. Global End-stage Renal Disease Therapeutics Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Dialysis Center Case Studies
Figure 11. Other Case Studies
Figure 12. End-stage Renal Disease Therapeutics Report Years Considered
Figure 13. Global End-stage Renal Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global End-stage Renal Disease Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global End-stage Renal Disease Therapeutics Market Share by Region: 2025 vs 2032
Figure 16. Global End-stage Renal Disease Therapeutics Market Share by Players in 2025
Figure 17. Global End-stage Renal Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by End-stage Renal Disease Therapeutics Revenue in 2025
Figure 19. North America End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America End-stage Renal Disease Therapeutics Market Share by Country (2021–2032)
Figure 21. United States End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe End-stage Renal Disease Therapeutics Market Share by Country (2021–2032)
Figure 25. Germany End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific End-stage Renal Disease Therapeutics Market Share by Region (2021–2032)
Figure 33. China End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America End-stage Renal Disease Therapeutics Market Share by Country (2021–2032)
Figure 41. Mexico End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa End-stage Renal Disease Therapeutics Market Share by Country (2021–2032)
Figure 45. Israel End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE End-stage Renal Disease Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Fresenius Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 49. Nikkiso Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 50. B.Braun Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 51. Baxter Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 52. Asahi Kasei Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 53. Nipro Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 54. Weigao Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 55. Toray Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 56. Medtronic Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 57. JMS Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 58. SB-KAWASUMI Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 59. Medica Group Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 60. Chongqing Shanwaishan Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 61. Amgen Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 62. Deltanoid Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 63. AbbVie Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 64. Sanofi Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 65. Ardelyx Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 66. AstraZeneca Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 67. Kyowa Hakko Kirin Revenue Growth Rate in End-stage Renal Disease Therapeutics Business (2021–2026)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
